<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)of
The Securities Exchange Act of 1934
Date of Report: November 15, 1999
COLORADO MEDTECH, INC.
----------------------
(Exact name of registrant as specified in its charter)
Colorado 000-12471 84-0731006
- ---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File I.R.S. Employer
of incorporation) Number) Identification No.)
6175 Longbow Drive
Boulder, Colorado 80301
-----------------------
(Address, including zip code, of principal executive offices)
(303) 530-2660
--------------
(Registrant's telephone number,
including area code)
<PAGE>
Item 2. Acquisition or Disposition of Assets.
On November 15, 1999, Colorado MEDtech, Inc. acquired CIVCO Medical
Instruments Co., Inc. pursuant to a Plan and Agreement of Share Exchange by and
among Colorado MEDtech, Inc., CIVCO Medical Instruments Co., Inc. and Victor
Wedel. CIVCO, a privately held company located in Kalona, Iowa, is a designer
and manufacturer of specialized medical products for ultrasound imaging
equipment and procedures and for minimally invasive surgery equipment and
procedures. Pursuant to the Plan and Agreement of Share Exchange, Colorado
MEDtech acquired all of the outstanding shares of CIVCO, as well as its Kalona
facility, from Victor Wedel, for consideration consisting of 736,324 shares of
Colorado MEDtech, Inc. common stock. The number of shares of common stock issued
by Colorado MEDtech was determined based upon a negotiated value of $15.00 per
share.
CIVCO's business focuses on supplying innovative product design,
manufacturing, distribution and support to the world's leading imaging original
equipment manufacturers (OEMs). CIVCO's annualized revenues are approximately
$10 million and it employs approximately 95 people. The CIVCO business will
remain at its current location and will operate as a subsidiary of Colorado
MEDtech. Charles Klasson will continue as President of CIVCO.
The description of the Agreement contained herein is qualified in its
entirety by reference to the Agreement which is attached hereto as Exhibit 2.1,
and incorporated herein by reference.
Item 7. Financial Statement and Exhibits.
(a) Financial Statements of Businesses Acquired.
As of the date of filing of this Current Report on Form 8-K, it is
impracticable for the Registrant to provide the financial statements required by
Item 7(a). In accordance with Item 7(a)(4) of Form 8-K, such financial
statements will be filed by amendment to this Form 8-K no later than sixty days
after the date this report must be filed.
(b) Pro forma financial information.
As of the date of filing of this Current Report on Form 8-K, it is
impracticable for the Registrant to provide the financial statements required by
Item 7(b). In accordance with Item 7(b) of Form 8-K, such financial statements
will be filed by amendment to this Form 8-K no later than sixty days after the
date this report must be filed.
-2-
<PAGE>
(c) Exhibits.
No. Description
--- -----------
2.1 Plan and Agreement of Share Exchange dated November 15, 1999, by and
among Colorado MEDtech, Inc., CIVCO Medical Instruments Co., Inc., and
Victor Wedel. As permitted by Item 601(b)(2), Exhibits and Schedules
listed in the Plan and Agreement of Share Exchange have been omitted,
but will be provided to the Commission upon request.
-3-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DATED, this 29/th/ day of November, 1999.
COLORADO MEDTECH, INC.
By: /s/ John V. Atanasoff
-------------------------------
John V. Atanasoff II
Chief Executive Officer
-4-
<PAGE>
Exhibit 2.1
PLAN AND AGREEMENT OF
SHARE EXCHANGE
BY AND AMONG
COLORADO MEDTECH, INC.,
CIVCO MEDICAL INSTRUMENTS CO., INC.,
AND
VICTOR WEDEL
Dated November 15, 1999
<PAGE>
PLAN AND AGREEMENT OF SHARE EXCHANGE
BY AND AMONG
COLORADO MEDTECH, INC.,
CIVCO MEDICAL INSTRUMENTS CO., INC.,
AND
VICTOR WEDEL
List of Schedules
Schedule 2.4 Shareholder Listing
Schedule 2.10 Financial Statements
Schedule 2.11 Material Adverse Changes
Schedule 2.13 Material Liabilities
Schedule 2.14 Accrued Taxes
Schedule 2.15 Real Property Owned or Leased by Civco
Schedule 2.17 Intellectual Property
Schedule 2.17.3 Employees Covered by Nondisclosure Agreements
Schedule 2.19 Material Contracts
Schedule 2.20 Litigation
Schedule 2.21 Company Transactions with Officers, Directors, or Shareholders
Schedule 2.22 Employment Agreements
Schedule 2.23 Employee Benefit Programs
Schedule 2.25 Bank Accounts
Schedule 2.27 Environmental Reports and Documents
List of Exhibits
A Real Property Description
B Escrow Agreement
C Registration Rights Agreement
D Warranty Deed
E Shareholder Certificate
F Civco Certificate
G Opinion of Civco Counsel
H Opinion of Civco Certified Public Accountants
I CMED Officer Certificate
J CMED Secretary Certificate
K Opinion of CMED Counsel
L Opinion of CMED Certified Public Accountants
i
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
<S> <C>
SECTON 1. SHARE EXCHANGE............................................. 2
1.1 The Share Exchange............................................... 2
1.2 Closing.......................................................... 2
1.3 Effect of Share Exchange......................................... 3
1.4 Share Exchange Adjustment........................................ 3
1.5 Evidence of Title................................................ 4
1.6 Title Review; Indemnification for Unsatisfactory Conditions...... 4
1.7 Matters Not Shown by the Public Records.......................... 4
1.8 Payment of Encumbrances.......................................... 4
1.9 Possession....................................................... 4
1.10 Damage to Real Property.......................................... 4
SECTION 2. REPRESENTATIONS AND WARRANTIES OF SHAREHOLDER............. 5
2.1 Organization; Articles, Bylaws................................... 5
2.2 Corporate Power.................................................. 5
2.3 Authorization and Enforceability................................. 5
2.4 Capitalization................................................... 6
2.5 Compliance with Other Instruments; None Burdensome............... 6
2.6 No Subsidiaries.................................................. 6
2.7 Effect of Agreement.............................................. 6
2.8 Government, Third Party Consents................................. 7
2.9 Compliance with Legal Requirements; Licenses and Permits......... 7
2.10 Financial Statements; No Undisclosed Liabilities................. 7
2.11 No Material Adverse Change....................................... 7
2.12 Books and Records................................................ 8
2.13 Material Liabilities............................................. 9
2.14 Tax Matters...................................................... 9
2.15 Title to Property; No Liens, Encumbrances, Etc................... 10
2.16 Facilities; Equipment; Condition................................. 10
2.17 Intellectual Property; Intangible Assets......................... 10
2.18 Insurance........................................................ 11
2.19 Material Contracts............................................... 11
2.20 Litigation....................................................... 12
2.21 Company Transactions with its Officers, Directors,
or Shareholder................................................... 12
2.22 Employees; Independent Contractors............................... 12
2.23 Employee Benefit Plans........................................... 13
2.24 Offering......................................................... 13
2.25 Bank Accounts.................................................... 13
2.26 No Finder; Broker Fees........................................... 13
2.27 Environmental and Health and Safety Matters...................... 13
2.28 Investment Representations....................................... 15
2.29 Year 2000 Compliance............................................. 17
2.30 Due Diligence.................................................... 17
2.31 Securities Act, Etc.............................................. 17
2.32 Names............................................................ 18
2.33 Real Property and Land Use....................................... 18
2.34 Material Misstatements or Omissions.............................. 18
SECT.ON 3. REPRESENTATIONS AND WARRANTIES OF CMED.................... 18
3.1 Organization; Articles, Bylaws................................... 18
3.2 Corporate Power.................................................. 19
3.3 Authorization.................................................... 19
</TABLE>
ii
<PAGE>
<TABLE>
<S> <C>
3.4 Government, Third Party Consents................................. 19
3.5 Current Public Filings........................................... 19
SECTION 4. CONDITIONS TO CLOSING..................................... 19
4.1 Conditions to Closing of CMED.................................... 19
4.2 Conditions to Close of Shareholder............................... 21
SECTION 5. OTHER COVENANTS AND AGREEMENTS............................ 22
5.1 Access to Information............................................ 22
5.2 Customer Contact................................................. 22
5.3 Business Relationships........................................... 22
5.4 No Transfer...................................................... 22
5.5 Employees........................................................ 22
5.6 Registration Right............................................... 23
5.7 Standstill....................................................... 23
5.8 Amendments....................................................... 23
5.9 Satisfaction of Conditions....................................... 23
5.10 Governmental Filings............................................. 23
5.11 Good Faith....................................................... 23
SECTION 6. TERMINATION............................................... 23
6.1 Methods of Termination........................................... 23
6.2 Effect of Termination............................................ 23
6.3 Procedure Upon Termination....................................... 24
SECTION 7. INDEMNIFICATION........................................... 24
7.1 General Indemnification Covenants................................ 24
7.2 Procedures for Indemnification Pursuant to Section 7.1........... 25
7.3 Certain Information.............................................. 26
7.4 Release by Shareholder........................................... 26
7.5 Indemnification by CMED.......................................... 27
7.6 No Rights of Shareholder Against CIVCO........................... 27
7.7 Limits on Indemnification; Escrow................................ 27
SECTION 8. MISCELLANEOUS............................................. 28
8.1 Notice........................................................... 28
8.2 Execution of Additional Documents................................ 29
8.3 Binding Effect; Benefits......................................... 29
8.4 Entire Agreement................................................. 29
8.5 Governing Law.................................................... 29
8.6 Arbitration; Consent to Jurisdiction............................. 29
8.7 Attorneys' Fees and Costs........................................ 30
8.8 Survival......................................................... 31
8.9 Waivers.......................................................... 31
8.10 Merger of Documents.............................................. 31
8.11 Incorporation of Exhibits and Schedules.......................... 31
8.12 Severability..................................................... 31
8.13 Assignability.................................................... 31
8.14 Effectiveness of Agreement....................................... 31
</TABLE>
iii
<PAGE>
This PLAN AND AGREEMENT OF SHARE EXCHANGE is entered into this November 15,
1999 by and among COLORADO MEDTECH, INC., a Colorado corporation ("CMED"), CIVCO
MEDICAL INSTRUMENTS CO., INC., an Iowa corporation ("CIVCO"), and VICTOR WEDEL,
the holder of all of the outstanding capital stock of CIVCO ("Shareholder").
RECITALS
A. CMED and Shareholder desire that CMED acquire all of the outstanding
securities of CIVCO (whether capital stock or instruments exercisable for or
convertible into capital stock of CIVCO, collectively, the "CIVCO Shares") and
be the sole shareholder of CIVCO pursuant to the terms and conditions set forth
in this Plan and Agreement of Share Exchange (the "Agreement").
B. CMED further desires to acquire certain real property, described on
Exhibit A attached hereto, together with all interests of Shareholder in vacated
streets and alleys adjacent thereto, all easements and other appurtenances
thereto, and all fixtures thereto and improvements contained thereon, owned by
Shareholder (collectively, the "Real Property") on which the CIVCO facility is
located, and in consideration for such Real Property, CMED agrees to issue
shares of common stock of CMED to Shareholder pursuant to the terms of this
Agreement.
C. In consideration for the CIVCO Shares and the Real Property,
Shareholder shall receive shares of common stock of CMED ("CMED Common Stock")
under the terms set forth in this Agreement.
D. CMED and Shareholder are entering into a separate Escrow Agreement of
even date herewith and attached hereto as Exhibit B, and a Registration Rights
Agreement of even date herewith and attached hereto as Exhibit C (collectively,
such agreements and all other documents delivered pursuant to this Agreement are
referred to herein as the "Documents").
SECTION 1. Share Exchange
1.1 The Share Exchange
------------------
At the Closing, and subject to the other terms and conditions of this
Agreement, CMED shall acquire from Shareholder all of the CIVCO Shares in
exchange for the issuance of 706,667 shares of CMED Common Stock to Shareholder,
subject to adjustment as provided Section 1.4 herein. Also at the Closing, and
subject to the other terms and conditions of this Agreement, CMED shall acquire
the Real Property in exchange for the issuance of 43,333 shares of CMED Common
Stock to Shareholder, also subject to adjustment pursuant to Section 1.4. The
CMED Common Stock to be issued to Shareholder pursuant to this Agreement is
referred to herein as the "CMED Shares".
1.2 Closing
-------
The closing of the transactions contemplated herein (the "Closing") shall
take place as soon as practicable after the satisfaction or waiver of each of
the conditions set forth in Section 5 or at such other time as the parties agree
(the "Closing Date"), but in no event shall the Closing take place later than
December 8, 1999. The Closing shall take place at
<PAGE>
the offices of Chrisman, Bynum & Johnson, P.C., 1900 Fifteenth Street, Boulder,
Colorado or at such other location as the parties agree.
1.2.1 Deliveries of Shareholder and CIVCO. Subject to the terms and
-----------------------------------
conditions of this Agreement, at the Closing, Shareholder and CIVCO shall
deliver, or cause to be delivered, to CMED:
1.2.1.1 stock certificates representing all of the outstanding
CIVCO Shares, duly endorsed in blank, or accompanied by stock powers duly
executed in blank, in form satisfactory to CMED
1.2.1.2 the Escrow Agreement in the form attached hereto as
Exhibit B executed by Shareholder;
1.2.1.3 the warranty deed in the form attached hereto as
Exhibit D executed by Shareholder;
1.2.1.4 the Registration Rights Agreement in the form attached
hereto as Exhibit C executed by Shareholder;
1.2.1.5 a certificate executed by Shareholder and in the form
attached hereto as Exhibit E certifying that each of the covenants,
conditions and agreements to be performed by Shareholder have been complied
with as of the Closing Date;
1.2.1.6 a certificate executed by the Secretary of CIVCO in
the form attached hereto as Exhibit F;
1.2.1.7 resignations of all officers and directors of CIVCO
from such positions except those persons continuing as officers or
directors of CIVCO;
1.2.1.8 an opinion executed by counsel to CIVCO and
Shareholder in the form attached hereto as Exhibit G; and
1.2.1.9 an opinion executed by the certified public
accountants to CIVCO in the form attached hereto as Exhibit H.
1.2.1.10 a document terminating the current lease on the Real
Property.
1.2.2 Deliveries of CMED. Subject to the terms and conditions of this
------------------
Agreement, at the Closing, CMED shall deliver, or cause to be delivered, to
CIVCO:
1.2.2.1 stock certificates evidencing the CMED Shares, less
such CMED Shares deliverable into escrow pursuant to Section 7.7.2 herein;
1.2.2.2 the Escrow Agreement in the form attached hereto as
Exhibit B executed by CMED;
2
<PAGE>
1.2.2.3 the Registration Rights Agreement in the form attached
hereto as Exhibit C executed by CMED;
1.2.2.4 a certificate executed by an officer of CMED and in
the form attached hereto as Exhibit I certifying that each of the
covenants, conditions and agreements to be performed by CMED have been
complied with as of the Closing Date;
1.2.2.5 a certificate executed by the Secretary of CMED in the
form attached hereto as Exhibit J;
1.2.2.6 an opinion executed by counsel to CMED in the form
attached hereto as Exhibit K; and
1.2.2.7 an opinion executed by the certified public
accountants to CMED in the form attached hereto as Exhibit L.
1.3 Effect of Share Exchange. The authorized and outstanding capital
------------------------
stock, Certificate of Incorporation and Bylaws of CIVCO shall not be amended,
modified or terminated by this Agreement or the transactions contemplated
herein.
1.4 Share Exchange Adjustment.
-------------------------
1.4.1 CIVCO Stock. Notwithstanding the other provisions of this
-----------
Section 1, if the net worth of CIVCO (total assets minus total liabilities,
the "CIVCO Net Worth") is less than $1,800,000 as of the Closing Date, the
number of CMED Shares issuable to Shareholder under Section 1.1 shall be
reduced by the difference between $1,800,000 and the CIVCO Net Worth as of
the Closing Date, divided by the per share price of $15.00. If CIVCO Net
Worth as of the Closing Date exceeds $1,800,000, there shall be no
adjustment to the number of CMED Shares issuable under Section 1.1. Closing
Date Net Worth will be calculated on the date five (5) calendar days
("Calculation Date") prior to the Closing Date. CIVCO will disclose to CMED
any material changes to Net Worth between the Calculation Date and the
Closing Date. Subject to any such material changes, Net Worth calculated as
of the Calculation Date shall be deemed to be the Closing Date Net Worth.
If at the Closing any manager of CIVCO declines to continue his employment
with CIVCO after the Closing, or at the Closing is or has been terminated,
and such termination or failure to continue employment creates an
obligation of CIVCO to pay severance to such manager, the number of CMED
Shares issuable to Shareholder under Section 1.1 shall be reduced by such
severance, divided by the per share price of $15.00.
1.4.2 Real Property. The number of CMED Shares issuable to
-------------
Shareholder with respect to the Real Property is based on total debt on the
Real Property of $536,000. To the extent debt on the Real Property at the
Closing differs from $536,000, the number of CMED Shares issued to
Shareholder with respect to the Real Property shall be adjusted up or down
as appropriate, using a per share price of $15.00. Mortgage pre-payment
penalties, if any, and related costs associated with the sale of the Real
Property shall be similarly deducted from the purchase price.
3
<PAGE>
1.4.3 No Fractional Shares. No fractional CMED Shares shall be
--------------------
issued hereunder and any fractional shares resulting from the calculation
in this Section 1.4 shall be rounded to the nearest whole share.
1.5 Evidence of Title. Shareholder shall furnish to CMED, at
-----------------
Shareholder's expense, an abstract of title certified to a current date, at
least ten (10) days prior to the Closing (the "Title Deadline"). Copies of
instruments as to which exception to title is taken by CMED or its counsel
("Exceptions") shall also be furnished to CMED at Shareholder's expense. This
requirement shall pertain only to instruments shown of record in the office of
the clerk and recorder of the designated county or counties. The title
abstract, together with any copies of instruments furnished pursuant to this
Section, constitute the title documents ("Title Documents"). CMED, or CMED's
designee, must require Shareholder, in writing, to furnish copies of instruments
identified as Exceptions no later than 10 (ten) days after Title Deadline.
1.6 Title Review; Indemnification for Unsatisfactory Conditions. CMED
-----------------------------------------------------------
shall have the right to inspect the Title Documents. Written notice by CMED of
unmerchantability of title or of any other unsatisfactory title condition shown
by the Title Documents shall be signed by or on behalf of CMED and given to
Shareholder on or before the Closing Date.
1.7 Matters Not Shown by the Public Records. Shareholder shall deliver to
---------------------------------------
CMED, on or before the Title Deadline, true copies of all leases, surveys and
similar materials in Shareholder's possession pertaining to the Real Property
and shall disclose to CMED all easements, liens or other title matters not shown
by the public records of which Shareholder has actual knowledge. CMED shall
have the right to inspect the Real Property to determine if any third party has
any right in the Real Property not shown by the public records (such as an
unrecorded easement, unrecorded lease, or boundary line discrepancy).
1.8 Payment of Encumbrances. Any encumbrance required to be paid shall be
-----------------------
paid at or before Closing, including the payment in full by CMED of the mortgage
on the Real Property by wire transfer to Firstar Bank Iowa N.A..
1.9 Possession. Possession of the Real Property shall be delivered to
----------
CMED at the Closing.
1.10 Damage to Real Property. In the event the Real Property shall be
-----------------------
damaged by fire or other casualty prior to time of Closing, in an amount of not
more than ten percent of the total purchase price, Shareholder shall be
obligated to repair the same before the Closing. In the event such damage is
not repaired within said time or if the damages exceed such sum, this Agreement
may be terminated at the option of CMED. Should CMED elect to carry out this
Agreement despite such damage, CMED shall be entitled to credit for all the
insurance proceeds resulting from such damage to the Real Property and
Inclusions, not exceeding, however, the total purchase price. Should any
Inclusion(s) or service(s) fail or be damaged between the date of this Agreement
and the date of Closing, then Shareholder shall be liable for the repair or
replacement of such Inclusion(s) or service(s) with a unit of similar size, age
and quality, or an equivalent credit, less any insurance proceeds received by
CMED covering such repair or replacement.
4
<PAGE>
1.11 Environmental Site Assessment. Shareholder, at CIVCO's expense,
-----------------------------
shall provide a Phase I site assessment report (or equivalent as requested by
CMED) (the "Report") on the Real Property to CMED not later than five (5) days
prior to the Closing. CMED shall have five (5) days to examine the Report. In
the event CMED objects to any hazardous conditions identified in the Report in
writing within five (5) days of receipt, then this Agreement shall terminate, at
CMED's option. CMED's receipt of the Report shall not limit Shareholder's
liability for the condition of the Real Property.
1.12 Survey. It is understood that the Real Property is presently being
------
surveyed, and Shareholder shall cause the survey to be completed at his expense.
If requested by CMED, the survey will be recorded at Shareholder's expense and,
if reasonably requested by CMED, an Affidavit of Surveyor will be obtained
explaining the discrepancies between the survey description and that contained
in the chain of title to the Real Property. If written notice of any
unsatisfactory condition disclosed by such survey is given by CMED to
Shareholder, Shareholder shall use reasonable efforts to correct said condition
prior to the date of Closing.
SECTION 2. Representations and Warranties of Shareholder
Shareholder represents and warrants to CMED as follows:
2.1 Organization; Articles, Bylaws. CIVCO is an Iowa corporation duly
------------------------------
organized and existing under, and by virtue of, the laws of the State of Iowa
and is in good standing under such laws. CIVCO has all requisite corporate
power and authority to own and operate its real, personal and intellectual
properties and assets, and to carry on its business as presently conducted and
planned to be conducted. CIVCO is not presently qualified to do business as a
foreign corporation in any jurisdiction, and the failure to be so qualified will
not have a material adverse effect on the CIVCO's business as now conducted or
as now proposed to be conducted. CIVCO has furnished CMED with a copy of the
articles of incorporation of CIVCO, as amended, (the "Articles") and certified
by the Secretary of State of the State of Iowa and a copy of the Bylaws, which
copies are true, correct and complete and contain all amendments through and as
of the Closing Date.
2.2 Corporate Power. CIVCO has all requisite legal and corporate power
---------------
and authority (i) to execute and deliver this Agreement and the Documents; (ii)
to sell the CIVCO Shares hereunder, and (iii) to carry out and perform its
obligations under the terms of the Documents.
2.3 Authorization and Enforceability. All corporate action on the part
--------------------------------
of CIVCO necessary for (i) the authorization, execution, delivery and
performance of this Agreement and the Documents by CIVCO, (ii) the
authorization, issuance, sale and delivery of the CIVCO Shares, and (iii) the
performance of all of CIVCO's duties and obligations hereunder and thereunder
has been taken. This Agreement and the Documents, when executed and delivered by
CIVCO and Shareholder, shall constitute the valid and binding obligations of
each of CIVCO and Shareholder, enforceable in accordance with their terms,
subject to the laws of general application relating to bankruptcy, insolvency
and the relief of debtors and rules of law governing specific performance,
injunctive relief or other equitable remedies.
5
<PAGE>
2.4 Capitalization. Immediately prior to the Closing, the authorized
--------------
capital stock of CIVCO will consist solely of 10,000,000 shares of common stock
(the "CIVCO Common Stock"), 1,600,000 of which are issued and outstanding. The
outstanding shares of CIVCO Common Stock have been duly authorized and validly
issued, and are fully paid and nonassessable. The CIVCO Shares when issued in
compliance with the provisions of this Agreement will be duly authorized,
validly issued, fully paid and nonassessable, and free of any liens or
encumbrances. The number of CIVCO Common Stock held by Shareholder, and all
outstanding options and warrants and any other obligations of CIVCO convertible
into or exercisable or exchangeable for capital stock of CIVCO, are set forth in
Schedule 2.4, and such listing is complete and accurate as of the Closing.
There are no options, warrants or other rights to purchase any CIVCO common
stock. There are no preemptive rights or rights of first refusal with respect
to the capital stock or other contracts or agreements which, through
antidilution protection or otherwise, obligate CIVCO to issue CIVCO common
stock. The offer, sale and issuance of all CIVCO Shares referred to in this
Section constituted transactions exempt from the registration requirements of
the Securities Act of 1933, as amended (the "Securities Act"), and applicable
Blue Sky laws, and were conducted in compliance with such laws.
2.5 Compliance with Other Instruments; None Burdensome. Neither CIVCO nor
--------------------------------------------------
Shareholder are in violation of any term or provision of any material mortgage,
indebtedness, indenture, contract, agreement, instrument, judgment or decree,
and to their knowledge neither CIVCO nor Shareholder are in violation of any
order, statute, rule or regulation applicable to CIVCO or Shareholder. The
execution, delivery and performance of and compliance with this Agreement and
the Documents, and the issuance and sale of the CIVCO Shares and the sale of the
Real Property have not resulted and will not result in any violation of, or
conflict with, or constitute a default under, any of the terms of any corporate
restriction or of any indenture, mortgage, deed of trust, pledge, bank loan or
credit agreement, corporate charter, bylaw or any instrument, document or
agreement by which Shareholder, the Real Property or CIVCO or its properties may
be bound or affected, or result in the creation of any mortgage, pledge, lien,
encumbrance or charge upon the Real Property or any of the properties or assets
of CIVCO or Shareholder.
2.6 No Subsidiaries. CIVCO does not own and has never owned any interest,
---------------
directly or indirectly, in any other corporation, person, company, limited
liability company, business, trust, partnership or other entity or association.
2.7 Effect of Agreement. The execution, delivery and performance of this
-------------------
Agreement by CIVCO and Shareholder and the consummation of the transactions
contemplated hereby will not, with or without the giving of notice or the lapse
of time, or both: (i) to their knowledge, violate any provision of law, statute,
rule or regulation to which CIVCO or Shareholder is subject; (ii) violate any
judgment, order, writ or decree of any court, arbitrator or governmental agency
applicable to CIVCO or Shareholder; (iii) have any effect on any of CIVCO's
permits, licenses, tariffs, orders or approvals or the ability of CIVCO to make
use of such permits, licenses, tariffs, orders or approvals; or (iv) result in
the breach of or conflict with any term, covenant, condition or provision of,
result in the modification or termination of, constitute a
6
<PAGE>
default under, or result in the creation or imposition of, any lien, security
interest, charge or encumbrance upon the Real Property or any of the properties
or assets of CIVCO or Shareholder pursuant to any charter, bylaw, commitment,
contract or other agreement or instrument to which CIVCO or Shareholder is a
party or by which any of its assets or properties or the Real Property are or
may be bound or affected or from which CIVCO or Shareholder derives benefit.
2.8 Government, Third Party Consents. All consents, approvals or
--------------------------------
authorizations of, and all designations, declarations or filings with any
governmental authority or of any third party required in connection with the
execution of this Agreement and the Documents on the part of CIVCO and
Shareholder, and the performance of the transactions contemplated thereby, have
been obtained by CIVCO and Shareholder, including for the offer, issuance or
sale of the CIVCO Shares, except for the qualification (or the taking of such
action which may be necessary to secure an exemption from qualification, if
available) of the offer and sale of the CIVCO Shares under applicable Blue Sky
laws, which filings and qualifications, if required, will be accomplished in a
timely manner prior to or promptly upon the completion of the Closing.
2.9 Compliance with Legal Requirements; Licenses and Permits. To the
--------------------------------------------------------
knowledge of Shareholder and CIVCO, the conduct by CIVCO of its activities as
currently conducted, or currently planned by CIVCO to be conducted, does not
violate or infringe any statute, ordinance, code or other law, rule, regulation,
order, technical or other standard, requirement or procedure enacted, adopted,
promulgated, applied or followed by any federal, state or local government or
authority, including without limitation any judgment against CIVCO
(collectively, the "Legal Requirements"), neither CIVCO nor Shareholder have
received notice of any violation by CIVCO of any Legal Requirements, and neither
CIVCO nor Shareholder have no knowledge or reason to know of any basis for the
allegation of any such violation.
2.10 Financial Statements; No Undisclosed Liabilities. CIVCO has
------------------------------------------------
delivered to CMED its unaudited balance sheet, statement of operations and
statement of cash flows as of and for the fiscal year ended September 30, 1999,
its audited balance sheet, statement of operations and statement of cash flows
as of and for the fiscal years ended September 30, 1998 and 1997 and the
unaudited balance sheet of CIVCO as of October 31, 1999 (the "Balance Sheet
Date") together with the unaudited statement of operations and statement of cash
flows for the one month period ended October 31, 1999 (collectively, the
"Financial Statements"). The Financial Statements are attached hereto as
Schedule 2.10 and are complete and correct in all material respects, and they
have been prepared in accordance with United States generally acceptable
accounting principles ("GAAP") on a consistent basis throughout the period
indicated. The Financial Statements accurately describe the financial condition
and operating results of CIVCO as of the date and during the periods indicated.
2.11 No Material Adverse Change. Except as disclosed in Schedule 2.11,
---------------------------
since the Balance Sheet Date, and excluding the transactions contemplated by the
Documents:
2.11.1 CIVCO has not entered into any transaction which was not in
the ordinary course of its business except as disclosed to CMED;
2.11.2 there has been no change in the condition (financial or
otherwise), business, property, assets, operations or liabilities of CIVCO
other than changes in the
7
<PAGE>
ordinary course of its business, none of which, individually or in the
aggregate, has had or is expected to have a material adverse effect on
CIVCO;
2.11.3 CIVCO has not incurred, assumed, endorsed or guaranteed any
debt, obligation or liability (contingent or otherwise) that individually
or in the aggregate is material to CIVCO;
2.11.4 CIVCO has not waived any valuable right or a material debt
owed to it;
2.11.5 there has been no damage to, destruction of or loss of
physical property (whether or not covered by insurance) materially
adversely affecting the condition (financial or otherwise), business,
property, assets, operations or liabilities of CIVCO;
2.11.6 there has been no resignation or termination of employment of
any officer or key employee of CIVCO or of any key independent contractor
of CIVCO, and CIVCO knows of no impending resignation or termination of
employment of any officer or key employee of CIVCO or of any key
independent contractor of CIVCO, that would have a material adverse effect
on the condition (financial or otherwise), business, property, assets,
operations or liabilities of CIVCO;
2.11.7 there have been no loans made by CIVCO to employees,
Shareholder, officers or directors other than travel advances, office
advances and sales commission advances made in the ordinary course of its
business;
2.11.8 CIVCO has not declared or made any payment of any dividend or
other distribution of the assets of CIVCO;
2.11.9 CIVCO has not sold, assigned, transferred or disposed of in
any way any of its interest in and to any patents, copyrights, trademarks,
tradenames, trade secrets, know how or other intangible assets of CIVCO;
2.11.10 there has been no termination, amendment, assignment,
modification or change to any material agreement to which CIVCO is a party
or by which it is bound which materially adversely affects the business,
assets, liabilities, financial condition, operations or prospects of CIVCO,
including compensation agreements with CIVCO's employees;
2.11.11 there has been no other event or condition of any character
that individually or in the aggregate materially and adversely affected the
business, assets, liabilities, financial condition, operations or prospects
of CIVCO.
2.11.12 there have been no distributions to Shareholder.
2.12 Books and Records. The books and records of CIVCO are located at
-----------------
CIVCO's offices at 102 First Street South, Kalona, Iowa. The books of account
and other financial and corporate records of CIVCO are in all material respects
complete and correct, and are maintained in accordance with good business
practices, as could reasonably be expected for a company the size and scope of
CIVCO (provided, however, that this representation does not diminish the
8
<PAGE>
representations in Section 2.10). The minute books of CIVCO, as made available
to CMED and its counsel, contain complete and accurate records of all meetings
and accurately reflect all other corporate action of Shareholder and directors
(and committees thereof) of CIVCO through the date hereof.
2.13 Material Liabilities. Except as described in the Financial
--------------------
Statements, CIVCO does not have any obligations or liabilities (whether accrued,
absolute or contingent), other than obligations or liabilities incurred in the
ordinary course of its business since the Balance Sheet Date and which have not
been material, either individually or in the aggregate.
2.14 Tax Matters
-----------
2.14.1 CIVCO'S fiscal year for income tax reporting purposes ends
September 30.
2.14.2 CIVCO has timely filed (including extensions) all tax returns
or reports that are required to have been filed by it with the appropriate
federal, state, county and local government agencies or instrumentalities,
that would have a material adverse effect on CIVCO if not filed. CIVCO has
paid or established reserves shown on the Balance Sheet for all income,
franchise, payroll and other taxes. An estimate of accrued taxes is set
forth in Schedule 2.14. There is no pending dispute with any taxing
authority relating to any of CIVCO's tax returns. CIVCO is not subject to
any proposed material liability for any tax to be imposed upon its
properties or assets for which there is not an adequate reserve reflected
in the CIVCO Financial Statements or accrued since the Balance Sheet Date.
No federal or state income or sales tax returns of CIVCO have been audited.
CIVCO has not executed or filed with any taxing authority any agreement
extending the period for assessment or collection of any taxes. Complete
and correct copies of the income tax returns of CIVCO for fiscal years
ending in 1995, 1996, 1997, and 1998 as filed with the Internal Revenue
Service and all state taxing authorities, together with all related
correspondence and notices, have previously been delivered to CMED. CIVCO
has not consented to having the provisions of Section 341(f) (which relates
to collapsible corporations) of the Code apply to it.
9
<PAGE>
2.15 Title to Property; No Liens, Encumbrances, Etc. CIVCO has good and
----------------------------------------------
marketable title to all of its real and personal properties and assets, and has
good title to all of its leasehold interests, in each case subject to no
mortgage, pledge, lien, lease, conditional sale agreement, security interest,
encumbrances or charge, other than (i) the lien of current taxes not yet due and
payable, and (ii) possible minor liens and encumbrances which do not in any case
materially detract from the value of the property subject thereto or materially
impair the condition (financial or otherwise), business, property, assets,
operations or liabilities of CIVCO and which have not arisen otherwise than in
the ordinary course of business. Schedule 2.15 contains a correct and complete
list of all real property owned by CIVCO, and a list (including the amount of
annual rents, lease term and a summary of the leased property) of all leases
under which CIVCO is a lessee. The properties and leases listed on Schedule 2.15
are sufficient for the conduct of CIVCO's business as currently or currently
proposed to be conducted. CIVCO is not in default under any lease listed on
Schedule 2.15 and does not occupy any real property in material violation of any
law, regulations or decree.
2.16 Facilities; Equipment; Condition. All of the furniture, fixtures or
--------------------------------
equipment, buildings, plants, warehouses and other real estate owned or used by
CIVCO in the conduct of its businesses ("Fixed Assets") is owned, operated or
leased by CIVCO and is in good condition and repair (ordinary wear and tear
excepted) and suitable for the uses for which intended. To the knowledge of
CIVCO and Shareholder, all such Fixed Assets are operated in conformity with all
applicable laws, ordinances, regulations, orders and other requirements relating
thereto currently in effect.
2.17 Intellectual Property; Intangible Assets.
----------------------------------------
2.17.1 Schedule 2.17 lists all patents, trademarks, copyrights and
material licenses owned by CIVCO or Shareholder or used in CIVCO's
business. Except as listed on Schedule 2.17, CIVCO owns or has the right to
use, free and clear of all liens, claims, judgments and restrictions, all
patents, trademarks, service marks, trade names, copyrights, licenses and
all trade secrets, including know-how, inventions, designs, processes,
computer programs and technical data, and rights with respect to the
foregoing necessary to conduct its business as now conducted or as planned
to be conducted or in the development, production, performance, operation
and sale of all products and services sold or proposed to be sold by CIVCO
(collectively the "Intellectual Property"), without infringing upon or
otherwise acting adversely to the right or claimed right of any person
under or with respect to any of the foregoing.
2.17.2 There is no pending or, to the knowledge of CIVCO,
threatened claim or proceeding against CIVCO relating to the Intellectual
Property, including without limitation claims of infringement,
misappropriation, or breach of contract.
2.17.3 Each of CIVCO's founders, employees, independent contractors
and other persons or entities who, either alone or in concert with others,
develop, invent, discover, derive, program or design secrets or other
information used in CIVCO's business, or who has knowledge of or access to
information relating to them, has entered into a written agreement with
CIVCO, (i) providing that these secrets and information are confidential
and proprietary to CIVCO and are not to be divulged or misused, and (ii)
10
<PAGE>
transferring to CIVCO all of such employee's or other person's right, title
and interest in and to such secrets and information and other intangible
assets to the extent permitted by applicable law. A list of such employees
is attached hereto as Schedule 2.17.3. There is no breach or, to the best
of CIVCO's knowledge, threatened breach of any such agreements.
2.18 Insurance. CIVCO has and will maintain fire, casualty and liability
---------
insurance policies, with extended coverage, of the type prudent and customary
for businesses of its size and type, sufficient in amount to allow it to replace
any of its properties or assets which might be damaged or destroyed.
2.19 Material Contracts. Except as listed on Schedule 2.19, CIVCO is not
------------------
a party to and is not bound by any contract, agreement, lease, commitment or
proposed transaction, judgement, order, writ or decree, whether written or oral,
absolute or contingent, other than:
2.19.1 contracts for the purchase of supplies and services entered
into in the ordinary course of business and that do not require payment of
more than $10,000 by CIVCO and do not extend for more than one year beyond
the date hereof;
2.19.2 sales contracts entered into in the ordinary course of
business;
2.19.3 agreements involving less than $10,000 guaranteeing,
indemnifying or otherwise becoming liable for the obligations or
liabilities of another, or involving less than $10,000 of compensating
balances, or agreeing to assure another person meets any financial
covenant;
2.19.4 contracts terminable at will by CIVCO on no more than 30
days' notice without cost or liability to CIVCO and that do not involve any
employment or consulting arrangement and are not material to the conduct of
CIVCO's business;
2.19.5 agreements that restrict the conduct of business anywhere in
the world.
For the purpose of this Section, employment and consulting contracts,
contracts with labor organizations, license agreements and any other agreements
relating to CIVCO's Intellectual Property (other than standard end user license
agreements) shall not be deemed to have been entered into in the ordinary course
of business of CIVCO. Copies of the agreements listed on Schedule 2.19
(collectively the "Material Contracts") have been furnished to CMED. The
Material Contracts are valid, binding and in full force and effect, and
enforceable by CIVCO in accordance with their respective terms, subject to the
laws of general application relating to bankruptcy, insolvency and the relief of
debtors and rules of law governing specific performance, injunctive relief or
other equitable remedies. CIVCO has no knowledge, or reason to know, of any
default or event (including the execution and performance of this Agreement and
the Documents) that, with notice or lapse of time or both, would conflict with
or constitute a breach of any Material Contract or would result in the creation
or imposition of any lien or encumbrance on CIVCO, or any of CIVCO's real,
personal or intellectual properties. CIVCO has no knowledge, or reason to know,
of any proposed or threatened cancellation, amendment or termination of any
Material Contract.
11
<PAGE>
2.20 Litigation. Except as described in Schedule 2.20, there are no
----------
actions, suits, proceedings or investigations pending in which CIVCO or
Shareholder is a party or against or affecting the Real Property or any of
CIVCO's properties, assets, business or financial condition before any court,
agency or other tribunal (nor, to the knowledge of CIVCO and Shareholder, is
there any basis therefor or threat thereof), (i) which, either in any case or in
the aggregate, might result in any material adverse change in the condition
(financial or otherwise), business, property, assets, operations or liabilities
of CIVCO, Shareholder or the Real Property, or in any impairment of the right or
ability of CIVCO to carry on its business as now conducted or as planned to be
conducted, or in any material liability on the part of CIVCO, or (ii) which
questions the validity of this Agreement or any action taken or to be taken in
connection herewith. Neither CIVCO nor Shareholder are in default or breach of
any order, writ, injunction or decree to which it is a party of any federal,
state, local or foreign court, department, agency or instrumentality.
2.21 Company Transactions with its Officers, Directors, or Shareholder.
-----------------------------------------------------------------
Except as listed on Schedule 2.21, CIVCO is not indebted, either directly or
indirectly, to any of its officers, employees, directors or Shareholder, or to
their respective spouses or children, in any amount whatsoever, other than for
payment of salary for services rendered and reasonable expenses. None of CIVCO's
officers, employees, directors or shareholders or any members of their immediate
families is indebted to CIVCO, nor do any officers, employees, directors or
shareholders have any direct or indirect ownership interest in any firm or
corporation which controls, is controlled by or under common control with CIVCO
or which competes with CIVCO, or with which CIVCO has a material supplier or
customer relationship, except with respect to any aggregate interest in less
than one percent (1%) of the securities of any corporation whose stock is
publicly traded. No officer, employee, director or shareholder of CIVCO or any
member of their immediate families is, directly or indirectly, interested in any
material contract with CIVCO (other than with respect to such person's ownership
of capital stock of CIVCO). CIVCO is not a guarantor or indemnitor of any
indebtedness of any other person, firm or corporation.
2.22 Employees; Independent Contractors. Except as listed on Schedule
----------------------------------
2.22, CIVCO has not entered into any agreement, written or oral, with any
current or former employee that will require CIVCO to make any payment to such
employee upon termination. True and complete copies of all written employment
agreements with key employees of CIVCO listed on Schedule 2.22 have been
furnished to CMED prior to the Closing. To the knowledge of CIVCO, no employee
or independent contractor of CIVCO is in violation of any term of any employment
or independent contractor agreement, confidentiality or nondisclosure agreement,
invention assignment agreement or any other contract or agreement relating to
the relationship of any such employee or independent contractor with CIVCO or
any other party because of the nature of the business conducted or planned to be
conducted by CIVCO. To the knowledge of CIVCO, none of its employees or
independent contractors are subject to any obligations (including any licenses,
agreements, covenants or agreements of any nature), or subject to any decree,
writ, judgment or order of any court or agency, that would interfere with his or
her ability to perform services to CIVCO under any employment or independent
contractor agreement with CIVCO, or that would conflict with CIVCO's business as
conducted or planned to be conducted. Neither
12
<PAGE>
the execution and delivery of the Documents, nor the carrying on of CIVCO's
business by the employees or independent contractors of CIVCO as currently
conducted or planned to be conducted, will, to CIVCO's knowledge, conflict with
or result in a breach of the terms, conditions or provisions, or constitute a
default under, any contract, covenant, or instrument under which any of such
employees and independent contractors is obligated, which conflict, breach or
default would be materially adverse to CIVCO. CIVCO does not have any collective
bargaining agreements covering any of its employees.
2.23 Employee Benefit Plans. Except as listed on Schedule 2.23, neither
----------------------
CIVCO nor Shareholder has any employee benefit plan, stock option plan, stock
appreciation plan, stock purchase plan, profit sharing plan, bonus plan or
arrangement, or retirement or deferred compensation plan (collectively "Plans").
Neither CIVCO nor Shareholder has any liability (contingent or otherwise) to any
other person (including a Plan trust or Plan) in respect of any profit sharing,
bonus, retirement, deferred compensation or other employee benefit plan or
arrangement that is maintained, sponsored or contributed to by another person.
2.24 Offering. The offer, issuance and sale of the CIVCO Shares to be
--------
issued in conformity with the terms of this Agreement constitute transactions
exempt from the registration requirements of Section 5 of the Securities Act and
applicable state securities laws.
2.25 Bank Accounts. Schedule 2.25 sets forth a correct and complete list
-------------
of each bank account, brokerage account, similar account and safe deposit box
maintained by CIVCO, and the names of all authorized signatories on such
accounts.
2.26 No Finder; Broker Fees. Except for Shareholder's obligation to
----------------------
Hanifen Imhoff & Co., neither CIVCO nor Shareholder has incurred, or will incur,
directly or indirectly, any liability for brokerage or finders' fees or agents'
commissions or any similar charges in connection with this Agreement.
Shareholder will indemnify and hold CMED harmless for any breach of this Section
2.26.
2.27 Environmental and Health and Safety Matters.
-------------------------------------------
2.27.1 Shareholder and CIVCO have obtained all material permits,
licenses and other authorizations which are required with respect to
Shareholder and CIVCO under all Applicable Environmental Laws. Shareholder
and CIVCO are in full compliance with all terms and conditions of the
required permits, licenses and authorizations, and is also in full
compliance with all other limitations, restrictions, conditions, standards,
prohibitions, requirements, obligations, schedules and timetables contained
in any Applicable Environmental Law, and any plan, order, decree, judgment,
notice or demand letter issued, entered, promulgated or approved
thereunder. Neither Shareholder nor CIVCO have received notice of any
asserted present or past failure to comply with Applicable Environmental
Law or Governmental Requirements or of any claim related thereto.
2.27.2 No Hazardous Materials have been incorporated in, used on,
stored on or under, released from, treated on, transported to or from, or
disposed of on or from the Real Property such that, under Applicable
Environmental Law (i) any such Hazardous Materials would be required to be
removed or cleaned-up (other than in the ordinary
13
<PAGE>
course of business) or remediated, or (ii) the owner or lessee of the Real
Property could be subjected to liability for the removal, clean-up or
remediation of such Hazardous Materials; and neither Shareholder nor CIVCO
have received notification from any Governmental Body or other third
parties relating to Hazardous Materials on or affecting the Real Property
or real property adjacent thereto or relating to any potential or known
liability under Applicable Environmental Law arising from the ownership or
leasing of the Real Property.
2.27.3 Environmental Definitions. Each of the following terms
-------------------------
will have the meaning indicated below:
"Applicable Environmental Law" means CERCLA, RCRA, the Federal Water
Pollution Control Act, 33 U.S.C. (S)(S) 1251 et seq., the Clean Air Act, 42
U.S.C. (S)(S) 7401 et seq., the Hazardous Materials Transportation Act (49
U.S.C. (S)(S) 1801 et. seq.), the Toxic Substances Control Act (15 U.S.C.
(S)(S) 2601 et. seq.), the Emergency Planning and Community Right to Know
Act of 1986 (42 U.S.C. (S)(S) 11001 et seq.), any similar provisions of
federal, state or local law in the jurisdictions where Shareholder's owned
or leased properties are located and the rules, ordinances and regulations
thereunder and any other local, state and/or federal laws, rules,
ordinances or regulations, whether currently in existence or hereafter
enacted, including any amendments, modifications or supplements thereof or
thereto, that govern or relate to:
(a) the existence, clean-up and/or remediation of contamination on Real
Property;
(b) the protection of the environment from spilled, deposited, emitted or
otherwise emplaced contamination;
(c) the control of hazardous wastes or toxic materials;
(d) the use, generation, transport, treatment, storage, disposal, removal
or recovery of Hazardous Materials, including building materials; or,
(e) underground storage tanks, whether empty, filled or partially filled
with any material, waste or substance.
"CERCLA" -- The Comprehensive Environmental Response, Compensation and
Liability Act, 42 U.S.C. (S)(S) 9601 et seq., as amended from time to time,
including without limitation as amended by the Superfund Amendments and
Reauthorization Act of 1986,Public Law No. 99-499, and regulations
promulgated thereunder.
"Governmental Requirements" means the following: Applicable Environmental
Law, the Americans with Disabilities Act of 1990 (42 U.S.C. (S)(S)12101 et.
seq.), the Architectural Barriers Act of 1968, the Endangered Species Act
(15 U.S.C. (S)(S) 1531 et seq.), and similar provisions under applicable
federal, state or local law, all as amended from time to time, and all
regulations and rules promulgated with regard to any of the above, and any
federal, state or local law, statute, ordinance, order, determination,
listing
14
<PAGE>
or regulation pertaining to any of the above or pertaining to Hazardous
Materials, health, environmental conditions, wetlands, endangered species
or industrial hygiene.
"Hazardous Materials" means any substance, material or product which as of
the date of this Agreement is "hazardous" or "toxic", or is a "hazardous
substance", "toxic substance", "solid waste", "hazardous waste", "hazardous
pollutant", "toxic pollutant", "hazardous air pollutant", "hazardous
chemical substance" or otherwise regulated under CERCLA or RCRA or other
laws, rules, ordinances or regulations or which has been or shall be
determined at any time by any agency or court to be hazardous or toxic
under any Applicable Environmental Law. The term "Hazardous Materials"
shall also include, without limitation: (i) raw materials, building
components, the products of any manufacturing or other activities on the
properties, wastes, petroleum, and source, special nuclear or by-product
material as defined by the Atomic Energy Act of 1954, as amended (42 U.S.C.
(S)(S) 2011 et seq., as amended); (ii) asbestos, polychlorinated byphenyls,
radioactive materials, explosives, radon, petroleum and petroleum by-
products; (iii) any substance, material or waste which is or becomes
regulated or prohibited by any federal, state or local rule or regulation
or requires special handling or notification of any Governmental Body in
its collection, storage, treatment, handling or disposal; and (iv)
hazardous substances listed in the United States Department of
Transportation Table (49 C.F.R. 172.101 and amendments thereto) or by the
Environmental Protection Agency or successors (40 C.F.R. 302 and amendments
thereto).
"RCRA" -- Resource Conservation and Recovery Act, 42 U.S.C. (S)(S) 6901 et
seq., as amended from time to time, including without limitation as amended
by the Used Oil Recycling Act of 1980, the Solid Waste Disposal Act
Amendments of 1980 and the Hazardous and Solid Waste Amendments of 1984,
and regulations promulgated thereunder.
2.27.4 Reports and Documents. Schedule 2.27 lists all environmental
---------------------
reports, investigations, surveys, inquiries communications, documents and
agreements, whether or not currently in effect, related to environmental
conditions of the Real Property, each of which have been provided to CMED.
2.27.5 Material Safety Data Sheets. CIVCO has provided CMED
---------------------------
access to all Material Safety Data Sheets delivered to CIVCO in connection
with any pollutants, contaminants, hazardous or toxic substances or
petroleum currently or in the past used in the business of CIVCO.
2.28 Investment Representations. Shareholder represents and warrants to
--------------------------
CMED that:
2.28.1 he is acquiring CMED Shares, if applicable, for his own
account for investment, not for the interest of any other person, not for
resale to any other person and not with a view to or in connection with a
sale or distribution;
2.28.2 he has provided the information related to Shareholder
requested in written due diligence requests made by CMED to Shareholder,
and that such information provided by him is true and correct in all
material respects;
15
<PAGE>
2.28.3 he has had an opportunity to ask questions of and receive
answers from representatives of CMED with respect to the acquisition of the
CMED Shares. CMED has made available to him all documents requested and has
provided answers to all such persons' questions relating to receipt of the
CMED Shares;
2.28.4 he acknowledges that, because the CMED Shares will at the
Closing not have been registered under the Securities Act of 1933, as
amended (the "Securities Act"), or applicable state securities laws, any
resale inconsistent with the Act may create liability on his part and/or
the part of CMED, and agrees not to assign, sell, pledge, transfer or
otherwise dispose of or transfer any of the CMED Shares unless registered
under the Securities Act and applicable state securities laws or he has
delivered an opinion of counsel satisfactory to CMED that such registration
is not required;
2.28.5 he is able to bear the economic risk of an investment in the
CMED Shares and, by reason of his business or financial experience or the
business or financial experience of his or her professional advisors who
are unaffiliated with and who are not compensated by CMED, directly or
indirectly, has the capacity to protect his own interests in connection
with the transactions contemplated hereby;
2.28.6 he acknowledges that all certificates of the CMED Shares
issued pursuant hereto, shall contain substantially the following legend:
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THEY
MAY NOT BE OFFERED OR TRANSFERRED BY SALE, ASSIGNMENT, PLEDGE OR OTHERWISE
UNLESS (I) A REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT IS IN EFFECT OR (II) THE CORPORATION HAS RECEIVED AN OPINION OF
COUNSEL, WHICH OPINION IS SATISFACTORY TO THE CORPORATION, TO THE EFFECT
THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT."
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ISSUED PURSUANT
TO, AND ARE SUBJECT TO AN AGREEMENT AND PLAN OF SHARE EXCHANGE AMONG
COLORADO MEDTECH, INC., CIVCO MEDICAL INSTRUMENTS, CO., INC. AND VICTOR
WEDEL, DATED NOVEMBER, 1999. A COPY OF SUCH AGREEMENT IS AVAILABLE AT THE
OFFICES OF THE CORPORATION."
2.28.7 his state of residence and mailing address is as shown on
the signature page hereto.
2.28.8 Shareholder agrees that, to the extent such Shareholder
receives CMED Shares at any time subsequent to the date of the Closing,
such Shareholder will reaffirm, in writing for the benefit of CMED, the
representations set forth in this Section 2.28 as of the date of the
issuance of the CMED Shares.
16
<PAGE>
2.29 Year 2000 Compliance. In all material respects, assets of CIVCO, and
--------------------
products sold and/or licensed by CIVCO in the conduct of its business and all
other products used in combination with products sold and/or licensed by CIVCO,
are designed to and will be capable of accurately processing date data, without
error, delay or the need for manual input with respect to date data,
specifically including without limitation date data which represents or
references the 20th and 21st centuries, including the years 1999 and 2000 and
February 29, 2000.
Without limiting the generality of the foregoing the equipment,
hardware, software and Intellectual Property owned, licensed, leased or
used in the CIVCO business include "Year 2000 capabilities". "Year 2000
capabilities" means the equipment, hardware, software and Intellectual
Property:
(a) will not abnormally end or provide invalid or incorrect results
as a results of date data, specifically including date data which
represents or references different centuries or more than one century
(b) will manage and manipulate data involving dates, including single
century formulas and multi-century formulas, and will not cause an
abnormally ending scenario within the application or generate
incorrect values or invalid results involving such dates; and
(c) provides that all date-related user interface functionalities and
data fields include the indication of century; and
(d) provides that all date-related data interface functionalities
include the indication of century.
CMED expressly acknowledges that CIVCO has relied on the representations
and warranties of third party vendors with respect to such vendors' products
used, sold or licensed by CIVCO.
2.30 Due Diligence. CIVCO has provided to CMED the information requested
-------------
in its due diligence request, and the information so provided was true and
correct in all material respects.
2.31 Securities Act, Etc. Neither CIVCO, nor its respective officers,
--------------------
directors, or controlling persons (a) have been convicted within the ten years
preceding the date of this Agreement of any felony or misdemeanor of the types
described in Rule 262 (b)(1) under the Securities Act, (b) are subject to an
order, judgment or decree of the types described in Rule 262(b)(2) under the
Securities Act, (c) are subject to an order of the SEC of the types described in
Rule 262(b)(3) under the Securities Act, (d) have been suspended or expelled
from, or suspended or barred from association with a member of, a national
securities exchange or as described in Rule 262(b)(4) under the Securities Act
or (e) are subject to an order or injunction as described in Rule 262(b)(5)
under the Securities Act.
17
<PAGE>
2.32 Names. Since the date of its inception, CIVCO has not used any trade
-----
name, d/b/a, or other name to identify itself, except CIVCO Medical Instruments
Co., Inc.
2.33 Real Property and Land Use.
--------------------------
2.33.1 Use and operation of the Real Property now and at the time
of Closing will be, in full compliance with all applicable building codes,
environmental, zoning and land use laws and other local, state and federal
laws and regulations.
2.33.2 Shareholder knows of no condemnation or eminent domain
proceeding pending or contemplated against the Real Property or any part
thereof.
2.33.3 The buildings and improvements which are part of the Real
Property are completely within the boundary lines of the Real Property and
do not violate any set back requirements and no structure of any kind
encroaches upon the Real Property. Now and at the time of Closing there
will be no material, physical, or mechanical defects in the Real Property
including without limitation, the plumbing, heating, air conditioning and
electrical systems and to the best of Shareholder's knowledge, all such
items are in good operating condition and repair in compliance with all
applicable governmental laws and regulations. There are no leases or other
third party obligations now in place which will affect the Real Property.
Shareholder has obtained all licenses, permits, easements, and rights-of-
way, including proof of dedication required from all governmental
authorities having jurisdiction over the Real Property or from private
parties for the normal use and operation of the Real Property and to ensure
vehicular and pedestrian ingress to and egress from the Real Property. The
Real Property is not in a high hazard or flood zone area designated by
local, state or federal governmental agencies including FEMA or any like
agency.
2.34 Material Misstatements or Omissions. No representations or warranties
-----------------------------------
by CIVCO or Shareholder in this Agreement, or any document, exhibit, statement,
certificate or schedule furnished to CMED by CIVCO or Shareholder pursuant
hereto, or in connection with the transactions contemplated hereby, contains any
untrue statement of a material fact, or intentionally omits to state any
material fact necessary to make the statements or facts contained herein or
therein in the context in which they were made not misleading.
SECTION 3. Representations and Warranties of CMED
CMED represents and warrants to Shareholder as follows:
3.1 Organization; Articles, Bylaws. CMED is a Colorado corporation duly
------------------------------
organized and existing under, and by virtue of, the laws of the State of
Colorado and is in good standing under such laws. CMED has all requisite
corporate power and authority to own and operate its real, personal and
intellectual properties and assets, and to carry on its business as presently
conducted and planned to be conducted.
18
<PAGE>
3.2 Corporate Power. CMED has all requisite legal and corporate power and
---------------
authority (i) to execute and deliver this Agreement and the Documents; (ii) to
issue and sell the CMED Shares hereunder; and (iii) to carry out and perform its
obligations under the terms of the Documents.
3.3 Authorization. All corporate action on the part of CMED necessary for
-------------
(i) the authorization, execution, delivery and performance of this Agreement and
the Documents by CMED, (ii) the authorization, issuance, sale and delivery of
the CMED Shares, and (iii) the performance of all of CMED's duties and
obligations hereunder and thereunder has been taken. This Agreement and the
Documents, when executed and delivered by CMED, shall constitute the valid and
binding obligations of CMED, enforceable in accordance with their terms, subject
to the laws of general application relating to bankruptcy, insolvency and the
relief of debtors and rules of law governing specific performance, injunctive
relief or other equitable remedies.
3.4 Government, Third Party Consents. All consents, approvals or
--------------------------------
authorizations of, and all designations, declarations or filings with any
governmental authority or of any third party required in connection with the
execution of the Documents on the part of CMED, and the performance of the
transactions contemplated thereby, have been obtained by CMED, including for the
offer, issuance or sale of the CMED Shares, except for the qualification (or the
taking of such action which may be necessary to secure an exemption from
qualification, if available) of the offer and sale of the CMED Shares under
applicable Blue Sky laws, which filings and qualifications, if required, will be
accomplished in a timely manner prior to or promptly upon the completion of the
Closing.
3.5 Current Public Filings. CMED is current in all filings it is required
----------------------
to make with the U.S. Securities and Exchange Commission and the Nasdaq Stock
Market pursuant to the Securities Exchange Act of 1934, and all such filings are
complete and correct in all material respects
SECTION 4. Conditions to Closing
4.1 Conditions to Closing of CMED. Unless waived in writing by CMED, the
-----------------------------
obligation of CMED to consummate the transactions contemplated in this Agreement
on the Closing shall be subject to the satisfaction of each of the following
conditions:
4.1.1 Representations and Warranties. All representations and
------------------------------
warranties of Shareholder shall be true and correct as of the Closing Date
as though such statements had been made on and as of such date, and a
certificate to the foregoing effect in the form attached hereto as Exhibit
4.1.1, dated as of the Closing Date and signed by Shareholder individually
shall have been delivered to CMED.
4.1.2 Performance of Obligations. All of the terms, covenants and
--------------------------
conditions of this Agreement to be complied with and performed by
Shareholder on or before the Closing shall have been duly complied with and
performed in all material respects on or before the date of the Closing,
including specifically CIVCO's obligations in Sections 5.2 and 5.5, and a
certificate to the foregoing effect, substantially in the form attached
hereto
19
<PAGE>
as Exhibit 4.1.2, dated as of the date of the Closing and signed by
Shareholder individually shall have been delivered to CMED.
4.1.3 Termination of Directors. CMED shall have received evidence of
------------------------
the termination of all existing contracts or agreements with any current or
former director of CIVCO effective as of the Closing Date.
4.1.4 Consents and Approvals. All necessary consents of and filings
----------------------
required to be obtained or made by Shareholder relating to the consummation
of the transactions contemplated herein shall have been obtained and made.
4.1.5 Certified Certificate of Incorporation and Certificate of
---------------------------------------------------------
Existence. CMED shall have received (i) CIVCO's Certificate of
---------
Incorporation, duly certified by the Secretary of State of Iowa no less
than thirty (30) days prior to the date of Closing; and (ii) a certificate,
dated as of a date no earlier than thirty (30) days prior to the date of
Closing, duly issued by the Secretary of State of Iowa, certifying that
CIVCO is in existence and authorized to do business.
4.1.6 Secretary's Certificate. CMED shall have received a
-----------------------
certificate, substantially in the form attached hereto as Exhibit 4.1.6,
dated as of the Closing Date and signed by the Secretary of CIVCO,
certifying as to (i) the authenticity of the signatures of the President or
any Vice President of CIVCO who is authorized to act on behalf of CIVCO
with respect to the transactions contemplated by this Agreement, and (ii)
the truth and correctness of attached copies of CIVCO's Certificate of
Incorporation (including amendments thereto), Bylaws (including amendments
thereto), and resolutions of the board of directors and Shareholder of
CIVCO approving the execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby.
4.1.7 Opinion of Counsel. CMED shall have received an opinion from
------------------
counsel for CIVCO and Shareholder, dated as of the date of Closing, in
substantially the form attached hereto as Exhibit 4.1.7.
4.1.8 Opinion of Certified Accountants. CMED shall have received an
--------------------------------
opinion from certified public accountants for CIVCO and for CMED dated as
of the Closing in substantially the form attached hereto as Exhibit 4.1.8.
4.1.9 Real Property. All terms, covenants and conditions hereof
-------------
relating to the Real Property to be complied with and performed by
Shareholder on or before the Closing shall have been duly complied with and
performed in all material respects on or before the date of the Closing.
Subject to tender of payment at Closing as required herein and compliance
by CMED with the other terms and provisions hereof, Shareholder shall
execute and deliver a good and sufficient warranty deed to CMED, at
Closing, conveying the Real Property free and clear of all taxes except the
general taxes for the year of closing, and except the lien of Firstar Bank
Iowa N.A., secured by a lien against the Real Property for a loan with a
remaining principal balance of approximately $526,994, which CMED shall
assume and pay. Title shall be conveyed free and clear of all liens for
20
<PAGE>
special improvements installed or approved as of the date of CMED's
signature hereon, whether assessed or not; except (i) utility easements,
(ii) those matters reflected by the Title Documents accepted by CMED in
accordance with Section 1.6, (iii) those rights, if any, of third parties
in the Real Property not shown by the public records accepted by CMED, and
(iv) subject to building and zoning regulations. CMED shall be satisfied
with the results of the Phase II site assessment on the Real Property.
4.1.10 Intellectual Property Assignments. Shareholder shall have
---------------------------------
assigned to CIVCO all intellectual property owned or licensed by
Shareholder and used in or reasonably related to the business of CIVCO.
4.1.11 Additional Documents. CMED shall have received such other
--------------------
documents as CMED may reasonably request to evidence the accuracy of any
representation or warranty made by Shareholder, or the performance of or
compliance with any covenants or obligations required by CIVCO or
Shareholder, or to otherwise facilitate the consummation of any of the
transactions contemplated by this Agreement.
4.2 Conditions to Close of Shareholder. Unless waived in writing by
----------------------------------
Shareholder, the obligation of Shareholder to consummate the transactions
contemplated in this Agreement on the Closing shall be subject to the
satisfaction of each of the following conditions:
4.2.1 Representations and Warranties. All representations and
------------------------------
warranties of CMED shall be true and correct as of the Closing Date as
though such statements had been made on and as of such date, and a
certificate to the foregoing effect in the form attached hereto as Exhibit
4.2.1, dated as of the Closing Date and signed by an officer of CMED shall
have been delivered to Shareholder .
4.2.2 Performance of Obligations. All of the terms, covenants and
--------------------------
conditions of this Agreement to be complied with and performed by CMED on
or before the Closing shall have been duly complied with and performed in
all material respects on or before the date of the Closing, and a
certificate to the foregoing effect, substantially in the form attached
hereto as Exhibit 4.2.2, dated as of the date of the Closing and signed by
an officer of CMED shall have been delivered to Shareholder.
4.2.3 Consents and Approvals. All necessary consents of and filings
----------------------
to be obtained or made by CMED relating to the consummation of the
transactions contemplated herein shall have been obtained and made.
4.2.4 Certificate of Good Standing. CMED shall have delivered to
----------------------------
Shareholder a certificate, dated as of a date no earlier than thirty (30)
days prior to the date of Closing, duly issued by the Secretary of State of
Colorado, certifying that CMED is in good standing and authorized to do
business.
4.2.5 Opinion of Counsel. Shareholder shall have received an opinion
------------------
from counsel for CMED, dated as of the date of Closing, in substantially
the form attached hereto as Exhibit 4.2.5.
21
<PAGE>
4.2.6 Opinion of Certified Accountants. Shareholder shall have
--------------------------------
received an opinion from certified public accountants for CMED dated as of
the Closing in substantially the form attached hereto as Exhibit 4.2.6.
4.2.7 Additional Documents. Shareholder shall have received such
--------------------
other documents as Shareholder may reasonably request to evidence the
accuracy of any representation or warranty made by CMED, or the performance
of or compliance with any covenants or obligations required by CMED, or to
otherwise facilitate the consummation of any of the transactions
contemplated by this Agreement.
SECTION 5. Other Covenants and Agreements
CMED, Shareholder and CIVCO each covenant that from the date hereof and
through the Closing, and continuing after the Closing to the extent necessary to
effect the terms of this Section:
5.1 Access to Information. CMED and its counsel, accountants and other
---------------------
representatives shall have full access during normal business hours to all
properties, employees, documents, books and records relating to the business and
operation of CIVCO. CIVCO and Shareholder shall furnish to CMED and its
representatives all data and information concerning the operations of the
business of CIVCO that may be reasonably requested. CMED will give CIVCO and
Shareholder reasonable notice of times it desires to review such information or
otherwise conduct its due diligence and shall use reasonable efforts to minimize
any disruption caused by such matters.
5.2 Customer Contact. Between the date hereof and the Closing Date, CMED
----------------
may contact the customers of CIVCO, including, without limitation, General
Electric Medical Systems, Acuson, Toshiba, Siemens and Boston Scientific. This
contact will be done in an appropriate and coordinated fashion with the
participation of CIVCO.
5.3 Business Relationships. Shareholder and CIVCO shall use all reasonable
----------------------
efforts to preserve present relationships with suppliers, customers, employees,
vendors, and others having relationships with the businesses of CIVCO. CIVCO
shall not engage in any activities or business practices outside the ordinary
course of business consistent with past practices without the prior written
approval of CMED and shall conduct its business and operations in compliance
with all applicable laws, statutes, rules, regulations, ordinances and orders.
For purposes of this Section, a purchase or lease, or agreement to purchase or
lease, capital equipment having a value of $1,000 or greater shall be considered
to be outside the ordinary course of business of CIVCO.
5.4 No Transfer. Shareholder will not issue, transfer, gift, assign,
-----------
pledge, encumber or otherwise dispose of any shares of capital stock of CIVCO
between the date hereof and the Closing Date.
5.5 Employees. CIVCO and Shareholder shall use its best efforts to assist
---------
CMED in the hiring or continuation of employment with CIVCO after the Closing of
CIVCO personnel and employees and of certain CIVCO senior managers on terms
acceptable to CMED.
22
<PAGE>
5.6 Registration Right. CMED shall register the CMED Shares issued to
------------------
Shareholder hereunder as provided in the Registration Rights Agreement.
5.7 Standstill. Shareholder agrees that until the Closing Date, or upon
----------
the earlier termination of this Agreement in accordance with Section 6, it will
not, directly or indirectly, hold discussion with, provide information to, or
solicit offers from other persons, corporations, limited liability companies,
partnerships, joint venture, association, trust, agency or other entity
regarding any acquisition of all or part of the CIVCO Shares or the Real
Property. CIVCO and Shareholder will promptly notify CMED in writing if any
person makes any offer or any inquiry relating to the foregoing to Shareholder
or any officer, director or representative of CIVCO.
5.8 Amendments. CIVCO agrees not to amend, revoke or suspend any
----------
provision in the CIVCO Charter or Bylaws except as requested by CMED in
connection herewith.
5.9 Satisfaction of Conditions. The parties hereto each shall use their
--------------------------
best efforts to satisfy any Conditions of Closing set forth in Section 4 herein
or in any other document executed in connection with this Agreement or the
transactions contemplated herein.
5.10 Governmental Filings. If any filings are required under federal,
--------------------
state or other securities laws for the delivery of the CMED Shares or the CIVCO
Shares, the parties will cooperate in such filings.
5.11 Good Faith. The parties will act in good faith in connection with the
----------
matters described herein.
5.12 Belgian Subsidiary CIVCO has applied to form a subsidiary entity in
------------------
Belgium (the "Belgian Sub"). As a part of the consideration for the transactions
contemplated by this Agreement, Shareholder shall promptly transfer to CMED's
designee all shares of stock or other equity in the Belgian Sub issued or to be
issued to Shareholder.
SECTION 6. Termination
6.1 Methods of Termination. The transactions contemplated herein may be
----------------------
terminated and/or abandoned at any time prior to the Closing as follows:
6.1.1 By written consent of CMED, CIVCO, and Shareholder.
6.1.2 By any of CMED, CIVCO, or Shareholder if: (i) the Closing
shall not have occurred on or before December 8, 1999 (the "Termination
Date"); or (ii) any court of competent jurisdiction of the United States or
any State shall have issued an order, judgment or decree (other than
temporary restraining order) restraining, enjoining or otherwise
prohibiting the consummation of the transaction contemplated hereby and
such order, judgment or decree shall have become final and nonappealable.
6.2 Effect of Termination. In the event of termination of this Agreement
---------------------
pursuant to Section 6.1, this Agreement (except for Sections which expressly
survive such termination,
23
<PAGE>
which shall continue) shall become void and of no effect, without any liability
on the part of the parties, unless the termination was the result of the
representations and warranties of a party being incorrect when made or the
breach by a party of a covenant herein contained, in which event the party whose
representations and warranties were incorrect or which breached such covenants
shall be liable to the other party for damages suffered by the other party.
6.3 Procedure Upon Termination. In the event of termination and/or
---------------------------
abandonment by any party pursuant to Section 6.1 hereof, written notice thereof
shall forthwith be given to the other party and the transactions contemplated by
this Agreement shall be terminated and/or abandoned, without further action by
any person. If the transactions contemplated by this Agreement are terminated
and/or abandoned as provided herein, each party will return (or certify the
destruction of) all documents, work papers and other information of any other
party relating to the transactions contemplated hereby, whether so obtained
before or after the execution of this Agreement, to the party furnishing the
same, except that such party may keep one copy thereof in a secure location for
its legal files.
SECTION 7. Indemnification
7.1 General Indemnification Covenants. Subject to the provisions of this
---------------------------------
Section 7, Shareholder as of the Closing Date, shall indemnify, defend, save and
keep CMED and its affiliates (including CIVCO), and their respective officers,
directors, successors and assigns (collectively, the "CMED Indemnitees"),
harmless against and from all liability, demands, claims, actions or causes of
action, assessments, losses, fines, penalties, costs, damages and expenses,
including without limitation, reasonable attorneys' fees, court costs and other
fees, disbursements and expenses (collectively "Damages"), sustained or incurred
prior to the second anniversary of the Closing Date by any of the CMED
Indemnitees as a result of, arising out of or by virtue of (i) any
misrepresentations, breach of any warranty or representation, or non-fulfillment
of any agreement or covenant on the part of CIVCO or Shareholder, whether
contained in this Agreement, any Document or any exhibit or schedule hereto or
thereto, or any written statement or certificate furnished or to be furnished to
CMED pursuant hereto or in any closing document delivered by CIVCO or
Shareholder to CMED in connection herewith; (ii) any Damages associated with
curing unsatisfactory title or survey conditions of the Real Property; or (iii)
cleanup costs associated with the Real Property or any claims, suits, actions,
demands, order, assessments, fines or penalties or other administrative
proceedings brought by (a) owners of real property adjacent to the Real Property
(or lessees of their real property) as a result of actual, threatened or claimed
release or migration of contamination from the Real Property to adjacent
properties; or (b) a local, state or federal agency, arising out of the
occurrence of or release or threat of release of contamination at, on, under, or
from the Real Property as a result of conditions or operations at the Real
Property on or before the Closing Date. Such obligations apply regardless of the
presence of a Third Party Claim (as defined below). For purposes of determining
the amount of Damages for which indemnification is provided hereunder (but not
for the purpose whether a breach of a representation, warranty or covenant has
occurred), each of the representations, warranties and covenants made by any
party in this Agreement or in any certificate or other instrument delivered
pursuant hereto, including, without limitation, the Documents, shall be deemed
to have been made without the inclusion of limitations or
24
<PAGE>
qualifications as to materiality such as the word "material," if with the
inclusion of such limitation or qualification the representation, warranty or
covenant was breached.
7.2 Procedures for Indemnification Pursuant to Section 7.1.
------------------------------------------------------
7.2.1 Promptly following the receipt by a CMED Indemnitee of notice
of a demand, claim, action, assessment or proceeding made or brought by a
third party, including a governmental agency (a "Third Party Claim") or
knowledge of the basis of a claim for Damages, the CMED Indemnitee
receiving the notice of the Third Party Claim or knowledge of the basis for
a claim: (i) shall notify Shareholder of its existence, setting forth the
facts and circumstances of which such CMED Indemnitee has received notice
or knowledge; and (ii) if the CMED Indemnitee giving such notice is a
person entitled to indemnification under this Section 7 (an "Indemnified
Party"), specifying the basis hereunder upon which the Indemnified Party's
claim for indemnification is asserted; provided, however, that a failure to
-------- -------
provide prompt notification shall not prevent or prejudice a claim under
this Section 7 except to the extent such failure has prejudiced the rights
or defenses of Shareholder.
7.2.2 The Indemnified Party shall, upon reasonable notice by
Shareholder, tender the defense of a Third Party Claim to Shareholder. If
Shareholder accepts responsibility for the defense of a Third Party Claim,
then Shareholder shall have the right to contest, defend and litigate the
Third Party Claim and shall have the exclusive right, in his discretion
exercised in good faith and upon the advice of counsel, and subject to the
consent of the Indemnified Party (which shall not be unreasonably withheld)
to settle any such matter, either before or after the initiation of
litigation, provided that at least ten (10) days prior to any such
--------
settlement, he shall give written notice of his intention to settle to the
Indemnified Party. The Indemnified Party shall have the right to be
represented by counsel at its own expense in any defense conducted by
Shareholder.
7.2.3 Notwithstanding the foregoing, in connection with any
settlement negotiated by Shareholder, no Indemnified Party shall be
required to: (i) enter into or be bound by or obligated under any
settlement (a) that does not include the delivery by the claimant or
plaintiff to the Indemnified Party of a release from all liability in
respect of such claim or litigation, (b) if the Indemnified Party shall, in
writing to Shareholder within the ten (10) day period prior to such
proposed settlement, unreasonably withhold its consent with respect to such
settlement proposal as contemplated by Section7.2.2, and desire to have
Shareholder tender the defense of such matter back to the Indemnified
Party, or (c) that requires an Indemnified Party to take any unreasonable
affirmative actions as a condition of such settlement; or (ii) consent to
the entry of any judgment that does not include a full dismissal of the
litigation or proceeding against the Indemnified Party with prejudice;
provided, however, that should the Indemnified Party disapprove of a
-------- -------
settlement proposal pursuant to clause (b) above, the Indemnified Party
shall thereafter have all of the responsibility for defending, contesting
and settling such Third Party Claim but shall not be entitled to
indemnification by Shareholder to the extent that, upon final resolution of
such Third Party Claim, Shareholder's liability to the Indemnified Party
but for this proviso exceeds what the liability to the Indemnified Party
would have
25
<PAGE>
been if Shareholder were permitted to settle such Third Party Claim in the
absence of the Indemnified Party exercising its right under Section 7.2.2.
7.2.4 If, in accordance with the foregoing provisions of this
Section 7.2, an Indemnified Party shall be entitled to indemnification
against a Third Party Claim, and if Shareholder shall fail to accept the
defense of a Third Party Claim which has been tendered in accordance with
this Section 7.2, the Indemnified Party shall have the right, without
prejudice to its rights of indemnification hereunder, in its discretion
exercised in good faith and upon the advice of counsel, to contest, defend
and litigate such Third Party Claim, and may settle such Third Party Claim,
either before or after the initiation of litigation, at such time and upon
such terms as the Indemnified Party deems fair and reasonable, provided at
least ten (10) days prior to any such settlement, written notice of its
intention to settle is given to Shareholder. If, pursuant to this Section
7.2, the Indemnified Party defends or settles a Third Party Claim for which
it is entitled to indemnification hereunder, the Indemnified Party shall be
reimbursed by Shareholder for the reasonable attorneys' fees, expert fees
and other expenses of defending the Third Party Claim which are incurred
from time to time, forthwith following the presentation to Shareholder of
itemized bills for said attorneys' fees, court costs and other expenses. No
failure by Shareholder to acknowledge in writing their indemnification
obligations under this Section 7 shall relieve them of such obligations to
the extent they exist.
7.3 Certain Information. The parties hereto shall furnish or cause to be
-------------------
furnished to each other (at reasonable times and at no charge) upon request as
promptly as practicable such information (including access to books and records)
pertinent to CIVCO, Shareholder, or CMED and assistance relating to CIVCO or
CMED as is reasonably necessary for the preparation, review and audit of
financial statements, the preparation, review, audit and filing of any tax
return, the preparation for any audit or the prosecution or defense of any
claim, suit or proceeding relating to any proposed adjustment or which may
result in Shareholder or CMED being liable under the indemnification provisions
of this Section 7.
7.4 Release by Shareholder. Shareholder, as of the Closing Date, hereby
----------------------
releases and discharges CIVCO and its officers and directors from, and agrees
and covenants that in no event will Shareholder commence any litigation or other
legal or administrative proceeding against, CIVCO or any of its officers or
directors, either in law or equity, relating to any and all claims and demands,
known and unknown, suspected and unsuspected, disclosed and undisclosed, for
damages, actual, consequential, or otherwise, past, present and future, arising
out of or in any way connected with their ownership of the equity securities of
CIVCO or any employment or consulting relationship (other than for wages or
employee benefits accrued but not yet paid, or under debts for borrowed money as
listed on a Schedule hereto) prior to or at the Closing Date. Except for this
Agreement and the agreements entered into hereunder, as of the Closing without
further action, the voting, preemptive, buy-sell, first refusal or similar
rights, employment or consulting rights, by agreement or statute, of a
shareholder of CIVCO, shall terminate as to securities of CIVCO and as to CIVCO.
This Section shall in no way release, waive or extinguish claims that
Shareholder or CIVCO has or will have against CMED arising in the past, present
or future, including under this Agreement and the agreements entered into
hereunder.
26
<PAGE>
7.5 Indemnification by CMED. Subject to the provisions of this Section 7,
------------------------
CMED agrees to indemnify, defend and hold Shareholder harmless against, and will
reimburse Shareholder on demand for, any Damages sustained or incurred prior to
the second anniversary of the Closing Date by Shareholder as a result of,
arising out of or by virtue of any misrepresentation, breach of any warranty or
representation, or non-fulfillment of any agreement or covenant on the part of
CMED, whether contained in this Agreement, any Document or any exhibit or
schedule hereto or thereto or any written statement or certificate furnished or
be to furnished to CMED pursuant hereto or in any Document delivered by CMED to
CIVCO or Shareholder in connection herewith. The procedures set forth in
Sections 7.2 and 7.3 shall be applied to any claim under this Section by a
Shareholder, and in construing such Sections, Shareholder shall be treated as
the "CMED Indemnitees" and "Indemnified Party" for such purposes and CMED shall
be treated as the " Shareholder." Such obligations apply regardless of the
presence of a Third Party Claim.
7.6 No Rights of Shareholder Against CIVCO. Shareholder has no claim or
--------------------------------------
cause of action, directly, by contribution, by subrogation or otherwise, against
CIVCO for any matter for which Shareholder must provide indemnification, defense
or hold harmless hereunder or under any other document or agreement.
7.7 Limits on Indemnification; Escrow.
---------------------------------
7.7.1 Threshold Neither CMED, CIVCO nor Shareholder shall assert any
---------
claim for indemnification hereunder against the other until such time as,
and solely to the extent that, the aggregate of all claims which such party
may have against the other shall exceed $25,000 (the "Indemnification
Threshold"); provided, however, that claims related to remediation of
-------- -------
unsatisfactory conditions related to the Real Property shall not be subject
to the Indemnification Threshold. For purposes of determining whether a
claim is subject to indemnification under this Section 7, and counted
toward the Indemnification Threshold, claims which in the aggregate are
material shall be counted toward the Indemnification Threshold and
indemnifiable hereunder even if any such claims individually are not
material.
7.7.2 Shareholder Escrow. CMED and Shareholder shall enter into an
------------------
agreement in the form of Exhibit B for the creation of an escrow account
(the "Escrow") into which an amount equal to six percent (6%) of the CMED
Shares issuable to Shareholder at the Closing (the "Escrow Consideration")
will be placed. The Escrow Consideration will be held in the Escrow until
the expiration of twelve (12) months after the Closing or such earlier date
as CMED in its sole discretion shall choose to terminate the Escrow, at
which time the portion of the Escrow Consideration which remains in the
Escrow and is not reserved against for the payment of any indemnification
claims made by CMED prior to such expiration, along with accrued interest
and less the cost of establishing and maintaining the Escrow, shall be
disbursed to Shareholder. CMED shall make claims initially against, and
such claims shall be paid by, the Escrow and only after that Escrow
Consideration has been exceeded will a claim be made against Shareholder.
If an indemnification claim is satisfied by the Escrow, the number of CMED
Shares used to satisfy such a claim shall be calculated at $15.00 per
share.
27
<PAGE>
7.7.3 Offset. CMED shall have the right, upon written notice, to
-------
offset indemnification amounts due to it pursuant to this Agreement
against payments due to Shareholder under this Agreement or any contract
contemplated by, or referred to in, this Agreement.
7.7.4 Cap. Notwithstanding the above terms of this Agreement,
---
neither CMED nor Shareholder shall be liable under this Section 7 for an
amount which exceeds the dollar amount calculated by multiplying twenty
five percent (25%) time the number of CMED Shares to be issued to
Shareholder hereunder times $15.00 per share.
7.7.5 Environmental Damages. Shareholder may be indemnified by
---------------------
Velma E. Skola for certain costs associated with environmental conditions
of the Real Property pursuant to that certain Closing and Indemnification
Agreement dated May 20, 1992 (the "Skola Agreement"). Shareholder and CMED
agree that Section 3 of the Skola Agreement refers to the May 22, 1991
report of Groundwater Resource Consultants, Inc., a copy of which has been
supplied to CMED (the "Groundwater Report"). Notwithstanding the
provisions of Section 7.1 regarding time period or Section 7.7.4 regarding
indemnity cap, in addition to Shareholder's indemnification obligations
under Section 7.1, Shareholder shall indemnify CMED for any Damages
pertaining to the environmental problems identified in the Groundwater
Report, but only to the extent Shareholder is actually indemnified by
Skola or under the Skola Agreement for such items.
SECTION 8. Miscellaneous
8.1 Notice. Any notice required or permitted hereunder shall be in
-------
writing and shall be sufficiently given if (i) personally delivered, (ii) mailed
by certified or registered United States mail, return receipt requested, or
(iii) sent by recognized air express courier for next business day delivery,
addressed as follows:
If to CMED: Colorado MEDtech, Inc.
6175 Longbow Drive
Boulder, CO 80301
Attn: Peter Jensen
Telephone: (303) 530-2660
Facsimile: (303) 581-1010
Copy to: Chrisman, Bynum & Johnson, P.C.
1900 15/th/ Street
Boulder, CO 80302
Attn: Christopher M. Hazlitt
Telephone: (303) 546-1300
Facsimile: (303) 449-5426
If to Shareholder: Victor Wedel
205 Hazel Drive
28
<PAGE>
Corona Del Mar, CA 92625
Telephone: (949) 760-1622
Facsimile: (949) 760-0385
Copy to: Shuttleworth & Ingersoll, P.C.
115 Third Street SE, Ste. 500
Cedar Rapids, IA 52406
Attn: Gary Streit
Telephone: (319) 365-9461
Facsimile: (319) 365-8725
(or to such other address as any party shall specify by written notice so
given), and shall be deemed to have been delivered as of the date so personally
delivered, three business days after so mailed, or one business day after the
date delivered to the air express courier.
8.2 Execution of Additional Documents. The parties hereto will at any
----------------------------------
time, and from time to time after the Closing Date, upon reasonable request of
the other party, execute, acknowledge and deliver all such further acts, deeds,
assignments, transfers, conveyances, powers of attorney and assurances as may be
required to carry out the intent of this Agreement, and to transfer and vest
title to any securities being transferred hereunder, and to protect the right,
title and interest in and enjoyment of all of the securities transferred,
delivered and conveyed pursuant to this Agreement; provided, however, that this
Agreement shall be effective regardless of whether any such additional documents
are executed.
8.3 Binding Effect; Benefits. This Agreement shall be binding upon and
-------------------------
shall inure to the benefit of the parties hereto and their respective heirs,
successors, executors, administrators and assigns. Notwithstanding anything
contained in this Agreement to the contrary, nothing in this Agreement,
expressed or implied, is intended to confer on any person other than the parties
hereto or their respective heirs, successors, executors, administrators and
assigns any rights, remedies, obligations or liabilities under or by reason of
this Agreement.
8.4 Entire Agreement. This Agreement, together with the exhibits,
-----------------
schedules and other documents contemplated hereby, constitute the final written
expression of all of the agreements between the parties, and is a complete and
exclusive statement of those terms. It supersedes all understandings, letters
of intent and negotiations concerning the matters specified herein. Any
representations, promises, warranties or statements made by either party that
differ in any way from the terms of this Agreement and the exhibits, schedules
and other documents contemplated hereby, shall be given no force or effect. No
addition to or modification of any provision of this Agreement shall be binding
upon any party unless made in writing.
8.5 Governing Law. This Agreement shall be governed by and construed in
--------------
accordance with the laws of the State of Colorado exclusive of the conflict of
law provisions thereof.
8.6 Arbitration; Consent to Jurisdiction. Any and all disputes arising
-------------------------------------
out of this Agreement which cannot be resolved through negotiations between the
parties shall be submitted
29
<PAGE>
to binding arbitration. If the parties fail to reach a settlement of their
dispute within fifteen (15) days after the earliest date upon which one of the
parties notified the other(s) of its desire to attempt to resolve the dispute,
then the dispute shall be promptly submitted to arbitration by a single neutral
arbitrator who is a former state or federal judge. Unless the parties agree
otherwise, the arbitration shall be conducted by Judicial Arbiter Group ("JAG")
or any similar arbitration organization using retired state or federal judges if
JAG is no longer in existence or is unable to conduct an arbitration in the
venue selected by the parties. Venue shall be Boulder, Colorado. The decision of
the arbitrator shall be final, nonappealable and binding upon the parties, and
it may be entered in any court of competent jurisdiction. The arbitrator shall
be bound by the laws of the state of Colorado and all rules relating to the
admissibility of evidence, including, without limitation, all relevant
privileges and the attorney work product doctrine. Discovery shall be permitted
in accordance with the rules and procedures of the state of Colorado unless
otherwise agreed to by the parties or ordered by the arbitrator on the basis of
strict necessity adequately demonstrated by the party requesting an extension of
time. The arbitrator shall have the power to grant equitable relief including
attorney's fees and costs, where applicable under law and shall not be entitled
to make an award of punitive damages. The arbitrator shall issue a written
opinion setting forth his or her decision and the reasons therefor within thirty
(30) days after the arbitration proceeding is concluded. The obligation of the
parties to submit any dispute arising under or related to this Agreement to
arbitration as provided in this Section shall survive the expiration or earlier
termination of this Agreement. Notwithstanding the foregoing, either party may
seek and obtain an injunction or other appropriate relief from a court to
preserve or protect intellectual property rights or to preserve the status quo
with respect to any matter pending conclusion of the arbitration proceeding, but
no such application to a court shall in any way be permitted to stay or
otherwise impede the progress of the arbitration proceeding.
Shareholder, CMED, and CIVCO hereby consent to the jurisdiction of JAG and the
courts of the State of Colorado and the United States District Courts for the
District of Colorado, as well as to the jurisdiction of all courts from which an
appeal may be taken from such courts, for the purpose of any arbitration, suit,
action or other proceeding arising out of any of their obligations arising
hereunder or with respect to the transactions contemplated hereby and expressly
waive any and all objections they may have as to venue in any of such courts.
8.7 Attorneys' Fees and Costs. In the event of any arbitration or
--------------------------
litigation being filed or instituted between two or more of the parties
concerning this Agreement, the Prevailing Party will be entitled to receive from
the other party or parties its attorneys' fees, experts' fees, costs and
expenses, whether or not such controversy, claim or action is prosecuted to
judgment or other form of relief. The "Prevailing Party" is that party which is
awarded judgment or other legal or equitable relief as a result of trial or
arbitration, or who receives or is entitled to receive a payment of money from
the other party in settlement of claims asserted by such party. If both parties
receive a judgment or other award of relief, the court or the arbiter shall
determine which party is the Prevailing Party, taking into consideration the
merits of the claims asserted by each party, the relative values of the
judgments or other forms of relief received by each party, and the relative
equities between the parties.
30
<PAGE>
8.8 Survival. All of the terms, covenants, conditions, warranties and
---------
representations contained in this Agreement and any Document shall survive the
execution hereof and the Closing hereunder in accordance with their terms and
all representations and warranties shall survive for twenty four (24) months
following the Closing Date.
8.9 Waivers. CMED, Shareholder, or CIVCO may, by written notice to the
--------
other: (i) extend the time for the performance of any of the obligations or
other actions of the other under this Agreement; (ii) waive any inaccuracies in
the representations or warranties of the other contained in this Agreement or in
any document delivered pursuant to this Agreement; (iii) waive compliance with
any of the conditions or covenants of the other contained in this Agreement; or
(iv) waive performance of any of the obligations of the other under this
Agreement. Except as provided in the preceding sentence, no action taken
pursuant to this Agreement, including without limitation, any investigation by
or on behalf of any party, shall be deemed to constitute a waiver by the party
taking such action of compliance with any representations, warranties, covenants
or agreements contained in this Agreement. The waiver by any party hereto of a
breach of any provision hereunder shall not operate or be construed as a waiver
of any prior or subsequent breach of the same or any other provision hereunder
nor as a waiver of any claim for breach of representation, warranty or covenant.
8.10 Merger of Documents. This Agreement and all agreements and documents
--------------------
contemplated hereby constitute one agreement and are interdependent upon each
other in all respects.
8.11 Incorporation of Exhibits and Schedules. All exhibits and schedules
----------------------------------------
attached hereto are by this reference incorporated herein and made a part hereof
for all purposes as if fully set forth herein.
8.12 Severability. If for any reason whatsoever any one or more of the
-------------
provisions of this Agreement shall be held or deemed to be inoperative,
unenforceable or invalid as applied to any particular case or in all cases, such
circumstances shall not have the effect of rendering such provision invalid in
any other case or of rendering any of the other provisions of this Agreement
inoperative, unenforceable or invalid.
8.13 Assignability. Neither this Agreement nor any of the parties' rights
--------------
or obligations hereunder shall be assignable by any party hereto without the
prior written consent of the other parties hereto. No assignment shall relieve
a party of its obligations hereunder.
8.14 Effectiveness of Agreement. This Agreement shall become effective
---------------------------
and binding on the parties hereto only when signed and delivered by each of the
parties hereto. There are no third party beneficiaries of this Agreement.
31
<PAGE>
IN WITNESS WHEREOF, the parties hereby execute this Plan and Agreement of
Share Exchange this 15/th/ day of November, 1999.
Colorado MEDtech, Inc.
By: /s/ John V. Atanasoff
----------------------
John V. Atanasoff, President
SHAREHOLDER
/s/ Victor Wedel
- --------------------------
Victor Wedel
CIVCO Medical Instruments Co., Inc.
By: /s/ Victor Wedel
----------------------
Victor Wedel, Chief Executive Officer
32
